YD Bio Limited Ordinary Shares (YDES) Earnings History
Annual and quarterly earnings data from 2020 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 30.4% | -286.5% | -276.6% |
| 2023 | 43.8% | -2.8% | 3.9% |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export YDES earnings history in CSV or JSON format
Free sign-in required to download data
YD Bio Limited Ordinary Shares (YDES) Earnings Overview
As of March 4, 2026, YD Bio Limited Ordinary Shares (YDES) reported trailing twelve-month net income of -$3M. The company earned $-0.87 per diluted share over the past four quarters, with a net profit margin of -2.8%.
Looking at the long-term picture, YDES's historical earnings data spans multiple years. The company achieved its highest annual net income of $9M in fiscal 2021.
YD Bio Limited Ordinary Shares is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including CAI (-$538M net income, -0.7% margin), VCYT ($66M net income, 0.1% margin), ADPT (-$80M net income, -0.9% margin), YDES has room to improve margins relative to the peer group. Compare YDES vs CAI →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$1M | -10509.7% | -$1M | $-0.56 | -276.6% | -286.5% |
| 2023 | $13,560 | -99.6% | $-9,847 | $0.00 | 3.9% | -2.8% |
| 2022 | $4M | -56.5% | -$2M | $0.41 | - | - |
| 2021 | $9M | +443.0% | -$2M | $0.59 | - | - |
| 2020 | -$3M | - | $-344,223 | $-0.17 | - | - |
See YDES's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs YDES Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare YDES vs AGIO
See how YDES stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is YDES growing earnings?
YDES TTM EPS: $-0.87. Net income: $-3M. Earnings growth: N/A.
What are YDES's profit margins?
YD Bio Limited Ordinary Shares net margin is -2.8%, with operating margin at -2.9%. Below-average margins reflect competitive or cost pressures.
How consistent are YDES's earnings?
YDES earnings data spans 2020-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.